The pharmaceutical company Novartis has announced that the schizophrenia drug Fanapt (iloperidone) is now available to adult patients.
Fanapt is an oral antipsychotic that is designed to be taken twice a day. It received FDA approval in May 2009.
Short-term clinical trials showed that taking the drug resulted in a significant improvement in symptoms, compared to patients on a placebo. The most common side effects were dry mouth, dizziness, fatigue, nasal congestion, drowsiness, rapid heart rate, and weight gain.
The effectiveness of taking Fanapt beyond 6 weeks has not yet been studied, so your doctor will need to monitor you closely if he or she has you continue the treatment past that point.